Bio-Path Holdings Navigates Market Volatility Amid Biotech Challenges
Bio-Path Holdings, a biotech company focused on cancer treatment, faces significant challenges due to market volatility, but its innovative RNAi technology offers hope for advancing cancer treatment.
2 minutes to read